- Home
- IPHA vs ARQ Comparison
IPHA vs ARQ Comparison
Compare IPHA & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- ARQ
- Stock Information
- Founded
- IPHA 1999
- ARQ 1996
- Country
- IPHA France
- ARQ United States
- Employees
- IPHA N/A
- ARQ N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- ARQ
- Sector
- IPHA Health Care
- ARQ
- Exchange
- IPHA Nasdaq
- ARQ NYSE
- Market Cap
- IPHA 160.1M
- ARQ 155.3M
- IPO Year
- IPHA 2019
- ARQ N/A
- Fundamental
- Price
- IPHA $2.18
- ARQ $5.09
- Analyst Decision
- IPHA Strong Buy
- ARQ Strong Buy
- Analyst Count
- IPHA 1
- ARQ 1
- Target Price
- IPHA $11.00
- ARQ $8.00
- AVG Volume (30 Days)
- IPHA 28.8K
- ARQ 276.9K
- Earning Date
- IPHA 03-27-2025
- ARQ 05-07-2025
- Dividend Yield
- IPHA N/A
- ARQ N/A
- EPS Growth
- IPHA N/A
- ARQ N/A
- EPS
- IPHA N/A
- ARQ N/A
- Revenue
- IPHA $20,831,349.00
- ARQ $114,466,000.00
- Revenue This Year
- IPHA $209.83
- ARQ $13.02
- Revenue Next Year
- IPHA $83.15
- ARQ $29.27
- P/E Ratio
- IPHA N/A
- ARQ N/A
- Revenue Growth
- IPHA N/A
- ARQ 14.33
- 52 Week Low
- IPHA $1.29
- ARQ $3.34
- 52 Week High
- IPHA $3.51
- ARQ $8.11
- Technical
- Relative Strength Index (RSI)
- IPHA 53.46
- ARQ 62.66
- Support Level
- IPHA $2.06
- ARQ $4.89
- Resistance Level
- IPHA $2.24
- ARQ $5.36
- Average True Range (ATR)
- IPHA 0.09
- ARQ 0.31
- MACD
- IPHA -0.01
- ARQ 0.08
- Stochastic Oscillator
- IPHA 53.33
- ARQ 72.85
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.